Chow, T., Stong, N., Desai, K., Tamim, S., Bjorklund, C., Hadala, J., Donahue, C., Koo, P., Petrlik, E., Katz, J., Gandhi, A., Trudel, S., Bahlis, N., Richardson, P., Amatangelo, M. (2025). Pharmacodynamic activity and clinical benefits of mezigdomide in high-risk biomarker subgroups from the CC-92480-MM-001 study. Blood. https://doi.org/10.1182/blood-2025-5697